Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain
Authors:
- 1 May 1997
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 7 (3) , 169-175
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Congenital muscular dystrophy with laminin α2 chain deficiency: Identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistryEuropean Journal of Pediatrics, 1996
- Expression of laminin subunits in human fetal skeletal muscleJournal of Molecular Histology, 1995
- Expression of laminin subunits in congenital muscular dystrophyNeuromuscular Disorders, 1995
- Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletalNeuromuscular Disorders, 1995
- Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy 22–24 April 1994, The NetherlandsNeuromuscular Disorders, 1995
- Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkageCell, 1995
- Dystroglycan is a binding protein of laminin and merosin in peripheral nerveFEBS Letters, 1994
- Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.Journal of Biological Chemistry, 1994
- 22nd ENMC Sponsored Workshop on Congenital Muscular Dystrophy held in Baarn, The Netherlands, 14–16 May 1993Neuromuscular Disorders, 1994
- Neural abnormalities in the dystrophic mouseJournal of the Neurological Sciences, 1975